Catalyst Wire Dossier Catalyst Wire Dossier

M-001 influenza vaccine

M-001 · BiondVax Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M-001 influenza vaccine, covering 2014-05-13 to 2014-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers [Phase 2]

See pricing